SciGen ranked among the top searched stocks on 12 days in the past month.


As of 2:30 PM on the 30th, SciGen is trading at 265,000 KRW, the same price as the previous day. This represents a 10.77% decline compared to October 8. SciGen is known as a company that develops, manufactures, and sells molecular diagnostic reagents.

Today, foreigners have a tentative net sale of 12,000 shares of SciGen, while institutions have a net purchase of 2,000 shares. Over the past five days, individual investors have net sold 47,366 shares, foreigners have net sold 32,072 shares, and institutions have net purchased 76,508 shares.


On October 29, SciGen was a market issue with the headline "Rise amid news of COVID-19 spread and re-lockdowns in various countries."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing